Macarate, Mirlinda W.
HRN: 08-15-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/19/2023
CEFTRIAXONE 1G (VIAL)
04/19/2023
04/26/2023
IV
2gms
Q24H
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes